Compare IART & CGBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IART | CGBD |
|---|---|---|
| Founded | 1989 | 2012 |
| Country | United States | United States |
| Employees | 4427 | 2500 |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 826.2M |
| IPO Year | 1996 | N/A |
| Metric | IART | CGBD |
|---|---|---|
| Price | $14.98 | $10.90 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 7 | 8 |
| Target Price | ★ $14.33 | $12.92 |
| AVG Volume (30 Days) | ★ 1.2M | 567.1K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 14.42% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.39 | $3.74 |
| Revenue Next Year | $3.40 | $1.80 |
| P/E Ratio | ★ N/A | $10.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.70 | $10.62 |
| 52 Week High | $16.42 | $14.32 |
| Indicator | IART | CGBD |
|---|---|---|
| Relative Strength Index (RSI) | 69.01 | 38.43 |
| Support Level | $12.90 | $10.68 |
| Resistance Level | $16.35 | $12.17 |
| Average True Range (ATR) | 0.81 | 0.29 |
| MACD | 0.07 | -0.09 |
| Stochastic Oscillator | 83.67 | 13.29 |
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.